Insider Trading June 16, 2026 05:44 PM

Joby Aviation Executive Papadopoulos Sells Shares Amidst Ongoing Certification Investments

President of Aircraft OEM divests $77,574 in stock as company reports Q1 2026 revenue of $24 million against $110 million net loss.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
JOBY

Didier Papadopoulos, President of Aircraft OEM at Joby Aviation, Inc. (NASDAQ:JOBY), executed a series of stock sales totaling $77,574 between June 15 and June 16, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The transactions were conducted to cover tax obligations associated with the vesting of restricted stock units (RSUs) and through a pre-approved 10b5-1 trading plan. These sales occur as Joby Aviation navigates a challenging financial period, reporting a Q1 2026 revenue of $24 million, which surpassed analyst forecasts of $20.2 million, yet recorded a GAAP net loss of $110 million. The company attributes this loss to continued investments in certification and manufacturing processes. Joby Aviation's stock has declined 29% year-to-date and 34% over the past six months, reflecting market sentiment around its operational progress and financial health.

Joby Aviation Executive Papadopoulos Sells Shares Amidst Ongoing Certification Investments
JOBY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Didier Papadopoulos sold 7,974 shares for $77,574 to cover tax obligations and via a 10b5-1 plan.
  • Joby Aviation reported Q1 2026 revenue of $24 million, beating forecasts, but incurred a $110 million net loss.
  • The net loss is attributed to ongoing investments in certification and manufacturing, impacting the aerospace and advanced manufacturing sectors.

Didier Papadopoulos, serving as President of Aircraft OEM at Joby Aviation, Inc. (NASDAQ:JOBY), has executed a series of stock transactions resulting in the sale of 7,974 shares of common stock. According to a Form 4 filing submitted to the Securities and Exchange Commission, the aggregate value of these sales reached $77,574. The transactions took place across two days, June 15 and June 16, 2026, with sale prices fluctuating between $9.42 and $9.83 per share. Current market data indicates the stock is trading at $9.34, marking a decline of 29% year-to-date and 34% over the trailing six-month period.

The sales were not discretionary but were driven by specific corporate mechanisms. On June 15, Papadopoulos sold 5,999 shares at $9.83 per share. This transaction was explicitly structured to cover tax liabilities incurred upon the release and settlement of restricted stock units (RSUs), a standard requirement under the terms of the RSU award. The following day, June 16, an additional 1,975 shares were sold at a weighted average price of $9.42 per share. This second tranche was executed via a pre-approved 10b5-1 trading plan adopted on September 2, 2025, involving multiple trades at prices ranging from $9.24 to $9.65.

Prior to these sales, on June 14, Papadopoulos acquired 11,641 shares through the vesting of RSUs. These units represent a contingent right to receive common stock upon vesting, with portions vesting on June 14, 2022, and the remainder scheduled for quarterly installments contingent on continued service. Following these transactions, Papadopoulos directly holds 148,455 shares of Joby Aviation common stock, alongside 46,566 unvested RSUs.

The executive activity coincides with Joby Aviation's financial reporting for the first quarter of 2026. The company reported revenue of $24 million, exceeding the forecasted $20.2 million. However, the company recorded a GAAP net loss of $110 million. This loss is attributed to ongoing investments in certification and manufacturing. There were no announcements regarding mergers, acquisitions, changes in business strategy, or leadership updates. Analyst firms have not issued new upgrades or downgrades following the earnings release.

Joby Aviation's stock valuation metrics suggest the stock is slightly overvalued relative to its Fair Value estimate. The company continues to advance operational capabilities, with investors monitoring financial updates to gauge progress. The absence of new analyst ratings and the ongoing net loss highlight the challenges in the sector as the company balances growth investments with financial performance.

Risks

  • The company's significant GAAP net loss of $110 million highlights financial strain from certification and manufacturing investments.
  • Stock performance has declined 29% year-to-date and 34% over six months, indicating market uncertainty regarding operational progress.
  • No new analyst upgrades or downgrades suggest a lack of immediate external validation for the company's financial trajectory.

More from Insider Trading

McGrath RentCorp Executive Disposes of Shares Amidst Quarterly Earnings Miss Jun 16, 2026 RA Capital Healthcare Fund Increases Position in Artiva Biotherapeutics Amid Regulatory Milestones Jun 16, 2026 Teradyne Director Marilyn Matz Executes $507K Stock Sale Under Pre-Arranged Plan Jun 16, 2026 Globe Life Executive Dolores Skarjune Executes $693K Stock Sale Following Strong Rally Jun 16, 2026 Williams-Sonoma Executive Disposes of Shares Under Pre-Arranged Plan Jun 16, 2026